Uncategorized

The health system blamed the layoffs on regulatory uncertainty and rising costs of providing care.

J&J is offering up to $100,000 in grant funding, mentorship and access to computing capabilities.

Minovia’s lead product is MNV-201, an autologous hematopoietic stem cell product that is enriched with allogeneic mitochondria.

Jefferies analysts called the proxy filing, which is a standard disclosure after a merger agreement, “much more intriguing than normal” given the regulatory turmoil it revealed.

Susan Monarez, already acting director of the CDC, said during her confirmation hearing that she sees no causal link between vaccines and autism.

  La implantología dental ha vivido una revolución en las últimas décadas gracias a la constante evolución de la tecnología, los materiales y el conocimiento científico. Lo que en sus inicios consistía en la simple colocación de …

Peter Marks, who headed the FDA’s Center for Biologics Evaluation and Research before being forced to resign in March, said the agency’s new risk-based COVID-19 vaccine framework contradicts the current administration’s push for transparency and gold-standard science.

Without providing further context, HHS Secretary Robert F. Kennedy Jr. says that Gavi needs to “start taking vaccine safety seriously” by considering “the best science available.”

Flagship Pioneering’s ProFound Therapeutics will use its proprietary technology to mine the expanded proteome for novel cardiovascular therapeutics. Novartis has promised to pay up to $750 million per target, though it has not specified how many targets it will go after.

Las enfermedades cardiovasculares son la principal causa de mortalidad en todo el mundo. Entre ellas, las enfermedades de las válvulas cardiacas representan un problema significativo, especialmente la estenosis de la válvula aórtica, cuya prevalencia aumenta con el envejecimient …